Cite Filings / DYN / 0000950170-23-056121

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Dyne Therapeutics, Inc. Filed 2023-10-30 Acc 0000950170-23-056121

Documents 1

10-Q Quarterly Report , dyn-20230930.htm

Around this filing

2024-05-02 10-Q Quarterly Report
2023-11-02 4 Chief Operating Officer sold 9,939 shares at $7.40 ($73,549)
2023-11-02 144 Sale of Securities
2023-10-30 8-K Results of operations
2023-10-30 10-Q Quarterly Report
2023-08-03 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading dyn-20230930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…